DUBLIN--(BUSINESS WIRE)-- The "US Hemophilia Market and Competitive Landscape - 2018" report has been added to ResearchAndMarkets.com's offering.

US Hemophilia Market and Competitive Landscape - 2018, provides comprehensive insights into Hemophilia pipeline, epidemiology, market valuations, product sales, market forecast, product forecasts, and market shares. This study accurately estimates and forecast Hemophilia market size and drug sales. This research also provides insights into Hemophilia epidemiology and late stage pipeline.

The research is classified into following sections - Hemophilia overview with definitions, symptoms, etiology, diagnosis, treatment options; Hemophilia pipeline insights covering late stage clinical trials pipeline; Hemophilia prevalence trends by countries; Hemophilia market size and forecast by countries, market events, trends; product sales and forecast by countries; market shares by countries.

Research Scope:

• Hemophilia pipeline: Find out the drugs in clinical trials for Hemophilia by stages, phase 3 clinical trials, phase 2 clinical trials, and phase 1 clinical trials, by pharmacological class, by company
• Hemophilia epidemiology: Find out the prevalence of Hemophilia in US; prevalence forecast to 2023
• Hemophilia products: Identify key products marketed and prescribed for Hemophilia by brand name, by molecule, by company, by branded / generic, in US
• Hemophilia market size: Find out the market size for Hemophilia drugs in US; Find out how the market advanced from 2014
• Hemophilia drug sales: Find out the sales of Hemophilia drugs in US
• Hemophilia drugs sales forecast: Sales forecast for Hemophilia drugs to 2023 in US
• Hemophilia market share analysis: Find out the market shares of Hemophilia drugs and outlook in US

For more information about this report visit https://www.researchandmarkets.com/research/xfv952/united_states?w=4

View source version on businesswire.com: https://www.businesswire.com/news/home/20181010005776/en/

Report Abuse